Giwinostat supply
Titre original de l'avis
Poland – Various medicinal products – DOSTAWA GIWINOSTATU
Score d'opportunité
Pourquoi ce score ?
Opportunité
52 / 100
Complexité
58 / 100
Facteurs de risque
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
- Pays
- Pologne
- CPV
- 33690000 - Various medicinal products
- Date limite
- Aug 18, 2026
Aperçu
Moderate opportunityFaits clés
- Supplies contract
- 1 lot
- Duration 12 MONTH
- Supply of giwinostat medicinal product to the University Children’s Clinical Hospital in Białystok.
- The lot concerns an oral suspension formulation specified as Givinostati hydrochloridum monohydricum 8.86 mg/ml, 140 ml, OP 40.
Afficher le résumé complet
Open EU-level supply tender for one lot: delivery of giwinostat to the University Children’s Clinical Hospital in Białystok, Poland. Award is price-only. Electronic submission via e-ProPublico is required. The notice includes explicit bid security and pharmaceutical authorization requirements. No contract value is provided in the structured data or XML notice.
Risques
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- If signatory authority is not evident from registry data, a power of attorney must be attached.
Administrative
- Offer must be submitted electronically via e-ProPublico.
- Offer must be signed with a valid qualified electronic signature by authorized persons.
Critères d'attribution
Lot 1
Acheteur
Localisation
Białystok, POL
Site web
Profil acheteur
Identifiant
542-25-34-063
Activité
Health
Lots (1)
LOT-0001
Giwinostat supply
Supply of giwinostat oral suspension to the hospital in Białystok. The lot description specifies 8.86 mg/ml oral suspension, 140 ml, pack OP 40. Performance location is Białystok, Poland. The lot information comes from structured data and XML notice.
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Liczba punktów = ( Cmin/Cof ) * 100 * waga gdzie: - Cmin - najniższa cena spośród wszystkich ofert - Cof - cena podana w ofercie
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Dostawa giwinostatu
Description TED originale
1 Givinostati hydrochloridum monohydricum 8,86 mg/ml zawiesina doustna 140 ml OP 40
Détails de la procédure
- Date de publication
- 06 Jul 2026
- Langues
- Polish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 465320-2026
Documents (1)
Appels d'offres similaires
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Score d'opportunité
Pourquoi ce score ?
Opportunité
52 / 100
Complexité
58 / 100
Facteurs de risque
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications